Myotonic dystrophy (DM) is the most common inherited neuromuscular disorder in adults with a global incidence of 1 per 8000. The DM mutation was found to be an expansion of an unstable CTG triplet repeat in the 3' untranslated region (3'UTR) of a gene encoding a serine-threonine protein kinase (DMPK). However, the mechanism by which it causes disease is unknown. We and others have found that the mutant DMPK mRNA is trapped within the nucleus of DM cells and forms distinct, stable foci of mRNA. In addition, we have demonstrated that the mutant DMPK 3'UTR mRNAhas significant negative effects on gene expression. Furthermore, we have identified that expression of the mutant DMPK 3'UTR mRNA in myoblasts causes defects in myoblast fusion and differentiation, demonstrating that this RNA work in trans on the expression of other transcripts, and causes a disease relevant cellular phenotype. This study is directed at understanding the molecular biology of DM by addressing the hypothesis that DM is a paradigm for RNA mediated disease processes. The proposed experiments will be aimed at assessing and determining the effect of the DMPK messenger RNA (mRNA) on gene expression. The effects of the normal and mutant DMPK 3'UTR mRNA will be studied initially at the cellular level, secondly from a biochemical persepective and finally in vivo through the creation of a transgenic murine model. The hypothesis to be tested by this proposal is that: Myotonic dystrophy is a disease in which dysregulation of RNA metabolism mediated by the mutant DMPK mRNA contributes to the pathophysiology of DM.
The specific aims of this proposal are directed at: 1) studying the effects of the DM mutation in a cell culture model, 2) identifying genes whose expression is altered by the presence of the mutant DMPK 3'UTR mRNA and 3) the establishment of a murine model to study the in vivo effects of the DM mutation on RNA metabolism and their contribution to DM pathogenesis. The long term objectives of this proposal are to understand the molecular mechanisms by which the DM mutation functions in order to provide insight into the pathophysiology of DM, to allow for the development of appropriate animal models, and to eventually lead to a more rational approach to therapeutic intervention in DM.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR045992-03
Application #
6375209
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Lymn, Richard W
Project Start
1999-04-09
Project End
2004-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
3
Fiscal Year
2001
Total Cost
$273,095
Indirect Cost
Name
University of Wisconsin Madison
Department
Genetics
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Kim, Yun K; Yadava, Ramesh S; Mandal, Mahua et al. (2016) Disease Phenotypes in a Mouse Model of RNA Toxicity Are Independent of Protein Kinase C? and Protein Kinase C?. PLoS One 11:e0163325
Yadava, Ramesh S; Foff, Erin P; Yu, Qing et al. (2016) TWEAK Regulates Muscle Functions in a Mouse Model of RNA Toxicity. PLoS One 11:e0150192
Gladman, Jordan T; Yadava, Ramesh S; Mandal, Mahua et al. (2015) NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity. Hum Mol Genet 24:251-64
Yadava, Ramesh S; Foff, Erin P; Yu, Qing et al. (2015) TWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy. Hum Mol Genet 24:2035-48
Kim, Yun Kyoung; Mandal, Mahua; Yadava, Ramesh S et al. (2014) Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity. Hum Mol Genet 23:293-302
Gladman, Jordan T; Mandal, Mahua; Srinivasan, Varadamurthy et al. (2013) Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1). PLoS One 8:e72907
Mahadevan, Mani S (2012) Myotonic dystrophy: is a narrow focus obscuring the rest of the field? Curr Opin Neurol 25:609-13
Ravel-Chapuis, Aymeric; BĂ©langer, Guy; Yadava, Ramesh S et al. (2012) The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing. J Cell Biol 196:699-712
Foff, Erin Pennock; Mahadevan, Mani S (2011) Therapeutics development in myotonic dystrophy type 1. Muscle Nerve 44:160-9
Amack, Jeffrey D; Reagan, Shannon R; Mahadevan, Mani S (2002) Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. J Cell Biol 159:419-29

Showing the most recent 10 out of 11 publications